Walleye Capital’s Sagimet Biosciences SGMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.04M Buy
+307,785
New +$2.83M ﹤0.01% 2405

Other funds holding SGMT

Walleye Capital's SGMT Position: Q3 2026 in Review

Walleye Capital opened a new position in Sagimet Biosciences (SGMT) in Q3 2026: 307,785 shares worth $3.04M. The stake represents ﹤0.01% of the portfolio and ranks #2405 among its holdings.

151 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.

  • Walleye Capital held 307,785 shares of Sagimet Biosciences worth $3.04M as of Q3 2026.
  • Sagimet Biosciences was a new Walleye Capital position in Q3 2026.
  • Sagimet Biosciences made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2405 holding.
  • 151 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.